The Hospital Immune System
Claryx detects each infection, traces how it's spreading, recommends a response, and confirms that it's gone, so your Infection Prevention and Control (IPC) team can focus on what matters most.
Stop outbreaks before they start
Claryx starts where it matters most: the patient. We sequence their infection and match its genetic fingerprint against other cases and the sinks, scopes, and surfaces around them, so you can see what it's connected to. Then we recommend next steps and confirm whether your intervention worked.
On any given day, 1 in 38 US hospital patients has an infection they developed in the hospital.
1Every hospital-acquired infection (HAI) adds an average of ~7.8 days to a patient's stay. Claryx prevents the infection, so those days never happen.
296% of transmission routes acted on were contained at the source in a prospective study using genomic intelligence.
3A tenth of a day off length of stay at a 526-bed hospital frees beds, generating up to $7.0mm in incremental profit, before a dollar of avoided infection cost.
4Value for every leader,
safety for every patient
From actionable signal to confirmation your intervention worked.
Infection Preventionist
Too often you're forced to act before you know how an infection is spreading, from another patient or a sink down the hall, and every day it goes unconfirmed is a day it keeps moving. Claryx confirms in real time, so your team spends its hours stopping outbreaks, not chasing coincidences.
Chief Financial Officer
On average, an HAI extends a patient's stay by ~7.8 days, which your hospital typically absorbs at cost with no additional reimbursement. On the razor-thin margins you're running, reducing average length of stay just 2% produces millions in profit.
Infectious Disease Physician
Claryx provides strain-level linkage between environmental reservoirs and patient infections within 72 hours, with a verification loop that confirms your intervention was effective. Now you have the tools to validate your intuition.
Chief Medical Officer
The patient choosing where to deliver their baby reads the same infection rate that CMS ranks and penalizes you on. It's a major part of your reputation that moves on evidence alone. Claryx connects the infections your lab already diagnosed and stops the next one before it spreads.
Fully managed,from sample to signal
Claryx runs the sampling, sequencing, and analysis. Every infection your lab diagnoses, we sequence and connect into a signal that points the resources you already pay for at where they matter most.
Outbreak identification with zero guesswork
Sample. Sequence. Intervene. Before any new infections.
Claryx deploys continuous genomic intelligence wherever your risk is highest, whether that's the ICU, the emergency department, or your transplant and immunocompromised wards.
AeroScan samples the air continuously, and our team samples wet reservoirs like sinks, high-touch surfaces, and building wastewater. Everything is sequenced at the Claryx lab, where CloneLink compares every infection and environmental sample at the strain level, surfacing matches between patients and the environment around them.
The result is a signal your team can act on in real time. Intervention speed increases by over 15x, and every infection Claryx prevents frees ~7.8 days of bed capacity for the next patient who needs it.
1 to 1
Attributable
The resolution required to tell coincidence from transmission
1/20th
cost
Claryx’s breakthrough IP cuts certain sequencing costs over twentyfold
I've taken care of patients with healthcare-acquired infections and seen the devastating toll they take on people and families. Yet too often our response relies on lagging signals like a positive culture. By then the pathogen has already moved. We need to see where it's building in the environment, so clinical teams can act before infections occur.
Dave Chokshi
43rd Health Commissioner of New York City
Every case of sepsis begins as an infection. Faster treatment saves lives, but the next frontier is identifying outbreaks earlier, preventing transmission, and delivering targeted antimicrobial therapy before patients ever become septic.
Russell Kerbel
MD MBA, Medical Director of Sepsis, UCLA Health
Talk To The Claryx Team
The Hospital Immune System